Multicentre clinical trial of diacerein in the treatment of the osteoarthritis

JIANG Ying,ZHANG Feng-chun,LI Xiao-xia,LI Yi-nong,HE Dong-yi,WANG Yi,GU Jie-ruo,TAO Yi,QI Wen-cheng,WANG Nian-song,SONG Hui,DUAN Ting,LIU Chong-yang,FANG Yong-fei,ZHAO Jian-hua,WANG Zhen-gang
DOI: https://doi.org/10.3969/j.issn.1001-6821.2008.01.004
2008-01-01
Abstract:Objective To evaluate the efficacy and safety of diacerein in osteoarthritis patients. Methods There were 372 cases enrolled in the multi-center clinical trail,who were fulfilled with the American College of Rheumatology criterias of knee/hand/hip diacerein. Patients were given diacerein 50 mg bid for 12 weeks.Results The joint pain and pain on walking for 20 meters (visual analog scale,VAS) of 318 cases of knee diacerein patients were greatly improved compared with baseline(P<0.01) . The incidence of related adverse events was 6.72% (25/372),most of which were mild-moderate gastrointestinal discomfort. No severe adverse events were occurred.Conclusion Diacerein is effective and safe in treating diacerein.
What problem does this paper attempt to address?